Editor LSA

Trader's Round Up: Rockwell Medical Inc (NASDAQ:RMTI), TG Therapeutics, Inc.(NASDAQ:TGTX), Horizon Pharma Inc (NASDAQ:HZNP), RR Donnelley & Sons Co (NASDAQ:RRD)

 

Lewes, DE -- (SBWIRE) -- 10/29/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Rockwell Medical Inc (NASDAQ:RMTI), TG Therapeutics, Inc.(NASDAQ:TGTX), Horizon Pharma Inc (NASDAQ:HZNP), RR Donnelley & Sons Co (NASDAQ:RRD)

Rockwell Medical Inc (NASDAQ:RMTI) opened its shares at the price of $11.79 for the day. Its closing price was $11.08 after losing -5.78% for the day. The company traded with the total volume of 1.39 million shares, while its average trading volume remained 2.83 million shares. The beta of RMTI stands at1.11. Rockwell Medical, Inc. operates as an integrated biopharmaceutical company in the United States and internationally.

Has RMTI Found The Bottom and Ready To Move Up? Find Out Here

TG Therapeutics, Inc.(NASDAQ:TGTX) percentage change plunged -8.52% to close at $3.65 with the total traded volume of 1.38 million shares, and average volume of 240,298.00 shares. The 52 week range of the stock remained $1.82 - $7.75, while its day lowest price was $2.97 and it hit its day highest price at $3.96. TG Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of innovative and medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs.

Has TGTX Found The Bottom And Ready To Gain Momentum? Find Out Here

Horizon Pharma Inc (NASDAQ:HZNP) started its trading session with the price of $4.56 and closed at $4.83 by scoring +6.62%. HZNP’s stocks traded with total volume of 1.35 million shares, while the average trading volume remained 895,142.00 shares. Horizon Pharma, Inc., a specialty pharmaceutical company, through its subsidiaries, develops and commercializes medicines for the treatment of arthritis, pain, and inflammatory diseases.

For How Long HZNP will Fight for Profitability? Read This Trend Analysis report

RR Donnelley & Sons Co (NASDAQ:RRD) ended its day with the loss of -0.82% and closed at the price of $17.90 after opening at $17.98. Stock traded during its last trading session with the total volume of 1.31 million shares, as compared to its average volume of 2.03 million shares. R.R. Donnelley & Sons Company provides integrated communication solutions to private and public sectors worldwide.

Has RRD Found The Bottom and Ready To Move Up? Find Out Here

About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/